Trueblood Wealth Management’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.06M Buy
8,097
+116
+1% +$27K 0.72% 33
2026
Q1
$1.95M Buy
7,981
+451
+6% +$105K 0.76% 26
2025
Q4
$1.56M Sell
7,530
-274
-4% -$54.2K 0.61% 50
2025
Q3
$1.45M Buy
7,804
+3
+0% +$514 0.56% 58
2025
Q2
$1.19M Sell
7,801
-366
-4% -$56.3K 0.5% 65
2025
Q1
$1.35M Sell
8,167
-211
-3% -$33K 0.63% 46
2024
Q4
$1.21M Sell
8,378
-2,228
-21% -$345K 0.6% 48
2024
Q3
$1.72M Sell
10,606
-249
-2% -$39.7K 0.86% 26
2024
Q2
$1.59M Buy
10,855
+40
+0.4% +$5.95K 0.9% 25
2024
Q1
$1.71M Buy
10,815
+386
+4% +$61.4K 0.98% 20
2023
Q4
$1.63M Buy
+10,429
New +$1.6M 1.03% 17

Other funds holding JNJ

Trueblood Wealth Management's JNJ Position: Q2 2026 in Review

Trueblood Wealth Management increased its Johnson & Johnson (JNJ) stake by 1.5% in Q2 2026, buying an estimated $27K and bringing the position to 8,097 shares worth $2.06M. The position accounts for 0.72% of the portfolio, ranked #33.

Trueblood Wealth Management first reported a position in JNJ in Q4 2023 and has held it in 11 quarters since. 4,665 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Trueblood Wealth Management held 8,097 shares of Johnson & Johnson worth $2.06M as of Q2 2026.
  • Trueblood Wealth Management bought 116 Johnson & Johnson shares in Q2 2026, an estimated $27K.
  • Johnson & Johnson made up 0.72% of Trueblood Wealth Management's portfolio in Q2 2026, its #33 holding.
  • Trueblood Wealth Management first reported a position in Johnson & Johnson in Q4 2023 and has held it in 11 quarters since.
  • 4,665 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Trueblood Wealth Management's 13F filing for Q2 2026, filed 27 Jul 2026.